This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
The
Four positively regulated and two negatively regulated genes were identified by transposon mutagenesis including genes potentially involved in iron transport and virulence. The promoter regions of selected CepR regulated genes and site directed mutagenesis of the
Using transposon mutagenesis and bioinformatics expression of twelve new genes have been determined to be regulated by the CepIR quorum sensing system. A
The ability of bacteria to adapt to diverse environments is dependent on the coordinate regulation of factors required to survive and proliferate in each niche. The CepIR quorum sensing system is one regulatory network that contributes to the response of
The CepIR system was originally identified in
Proteomics and promoter based approaches have been used to identify genes regulated by the CepIR quorum sensing system. Proteome analysis was used to compare the protein profiles of
Identification of genes directly and indirectly regulated by CepR is a key step to understanding this regulatory system and the regulatory hierarchies that mediate the adaptation
LuxR homologs have been shown to bind to specific sequences referred to as
Lewenza et al. identified a potential
Nine Tn
To confirm the observations in the plate assay, expression of the unique AHL responsive
The predicted promoter regions for the three positively regulated genes containing the Tn
To identify a consensus
To determine if the putative
To improve the specificity of the
The new PSSM file was used to search the
In this study we used a computational genome screen and experimental approaches to identify
In a screen of approximately 25,000 transposon mutants we only identified six loci with AHL responsive genes. The screening assay was dependent on the visual identification of colonies that were either blue or white in the presence or absence of AHL on medium with X-gal. Although we were able to detect as little as two-fold differences in expression with this assay, we would not detect gene fusions expressed in both the presence and the absence of AHL since we did not attempt to identify mutants with varying shades of blue. For example, although CepR positively regulates
Lewenza et al [
The use of bioinformatics to identify CepIR regulated genes has several advantages that are complementary to the experimental methods used to search for CepIR regulated genes. Procedures such as transposon mutagenesis, promoter libraries, microarray analysis or proteomics are dependent on the transcription and expression levels of the genes and on the conditions used in the study. Furthermore, the genes and proteins identified by these approaches may be regulated directly or indirectly by CepR. The use of a motif in a genome-wide search for CepIR regulated genes may identify niche specific genes that may only be expressed in certain conditions. Identification of a
When searching the genome using the first generation
Interestingly, the MEME program identified a
We identified a
It is difficult to compare the extent of overlap between the genes identified using the bioinformatics approach to those identified by Aguilar et al. [
Strains of
We have identified several new CepR regulated genes using transposon mutagenesis and
Unless otherwise stated all molecular biology reagents were purchased from Invitrogen Life Technologies (Burlington, Ontario) and all chemicals purchased from Sigma Chemical Co. (St. Louis, Mo.). The strains and plasmids used in this study are listed in Table
AHLs were extracted from culture supernatants of K56-2 as previously described [
DNA manipulations were performed generally as described by Sambrook
Mutagenesis of
The Altered Sites® II
Putative promoters identified in this study were PCR amplified using the primers listed in Table
Five ml overnight cultures of K56-2, K56-dI2 and K56-R2 hosting the
Nucleotide sequence obtained from DNA flanking the transposon insertions was used with BLASTN to determine the location of the insertion in the unpublished genome sequence of
CC designed the
This study was supported by a grant from the Canadian Cystic Fibrosis Foundation to PS. The authors thank J. Parkhill and M. Holden at the Welcome Trust Institute for access to the annotation data of
OHL responsive genes identified by Tn
| Transposon Mutant | Orfa | Predicted start codonb | Location of insertb | Gene/domain homologyc | OHL effect on expressiond |
| K56-I2-P1, K56-I2-P2 | BCAM0392 | 2:445357 | 2:444971 | COG1835: Predicted acyltransferases | + |
| K56-I2-P3 | BCAM0957 | 2:1062298 | 2:1060868 | + | |
| K56-I2-P5, K56-I2-P10 | BCAS0293 | 3:328037 | 3:328810 |
|
+ |
| K56-I2-P9 | BCAM2631 | 2:2981279 | 2:2980753 | COG2860: predicted membrane protein | - |
| K56-I2-P12 | BCAM2630 | 2:2979794 | 2:2980345 | + | |
| K56-I2-2PB2 | no gene | 2:2980336 | - | ||
| K56-I2-NB12 | BCAM1187 | 2:1298085 | 2:1297891 | COG4774, Outer membrane receptor | - |
a Open reading frame designation from the unpublished annotation of the
b Locations reported as chromosome:nucleotide.
c Gene and domain homologies determined using BLASTP.
d Effect of OHL on expression of the
Identification of a
| Gene | direction | Sequencec | bp to ORFd | |
| First Generation Motif Sequencesa | ||||
|
|
||||
|
|
2.23E-11 | + | CACC |
72 |
|
|
6.53E-10 | + | TACA |
116 |
|
|
2.24E-09 | - | GAAG |
159 |
|
|
2.60E-09 | + | TCTT |
54 |
| Acyltransferase | 1.13E-07 | - | AGGG |
3 |
|
|
1.25E-07 | - | CCAG |
115 |
|
|
|
|||
|
|
||||
| Second Generation Motif Sequencesf | ||||
|
|
||||
|
|
4.79E-11 | + | CACC |
72 |
|
|
6.11E-11 | + | TACA |
116 |
| MST072 | 4.01E-09 | + | AAAA |
56 |
|
|
2.16E-08 | - | GAAG |
159 |
| MST028 | 5.32E-07 | - | CTTT |
140 |
|
|
2.60E-09 | + | TCTT |
54 |
| MST005 | 1.24E-06 | + | CAAC |
206 |
| MST068 | 1.60E-06 | - | CGTT |
138 |
| MST011 | 1.80E-06 | + | TGTC |
76 |
| MST059 | 2.41e-06 | + | ATGG |
118 |
|
|
|
|||
a The promoter regions of 6 genes experimentally determined to be positively regulated by CepR used to search for common motifs with the MEME (Multiple EM for Motif Elicitation) program.
b The
c The boxed region represents the region determined to be required for
d The number of base pairs to the start codons predicted by alignment with homologous genes.
e Underlined bases are conserved in at least 4 of 6 sequences.
f The promoter regions of 10 genes experimentally determined to be positively regulated by CepR used to search for common motifs with MEME.
g Underlined bases are conserved in at least 7 of 10 sequences.
| Motif namea | Positionb | bpc | gened | Gene/domain and predicted functione |
|
|
||||
|
|
||||
| MST2008 (-) | 1:806161 | 45 | BCAL0738(-) | COG0793: Periplasmic protease; cell envelope biogenesis |
| MST2009 (+) | 1:901874 | 295 | BCAL0831 (+) | |
| MST2031 (-) | 1:2662911 | 104 | BCAL2406(-) | COG0859, |
| MST2048 (-) | 2:211218 | 106 | BCAM0183 (+) | COG3468, autotransporter type V secretion, |
| MST2050 (+) | 2:1129604 | 172 | BCAM1015(-) | COG3203: Outer membrane protein |
| MST2068 (-) | 3:174253 | 153 | BCAS0156(+) | COG1680: ampC, β-lactamase class C |
|
|
||||
|
|
||||
|
|
||||
| MST2014 (-) | 1:1228119 | 131 | BCAL1124 (+) | Conserved hypothetical protein |
|
|
1:1484174 | 140 | BCAL1354(-) | COG4104: conserved hypothetical protein ( |
| MST2030 (-) | 1:2567308 | 41 | BCAL2313 (+) | hypothetical protein |
| MST2052 (+) | 2:1249946 | 118 | BCAM1149 (+) | hypothetical protein |
| MST2056 (-) | 2:1667312 | 57 | BCAM1502 (+) | hypothetical protein (Chemoreceptor |
| MST2063 (-) | 2:2720454 | -19 | BCAM2417 (+) | hypothetical protein |
| MST2067 (+) | 2:3070180 | 254 | BCAM2713(-) | hypothetical protein |
| MST2071 (+) | 3:836110 | 63 | BCAS0753(+) | hypothetical protein |
|
|
||||
|
|
||||
|
|
||||
| MST2002 (-) | 1:273243 | 21 | BCAL0232 (+) | Elongation factor Tu |
| MST2005 (+) | 1:390962 | 47 | BCAL0358 (-) | COG0308: Aminopeptidase N |
|
|
1:778996 | 101 | BCAL0716 (+) | COG1250: |
| MST2010 (-) | 1:963495 | 59 | BCAL0886 (+) | COG0183: |
| MST2022 (-) | 1:1602043 | 50 | BCAL1448(-) | COG0525: |
| MST2023 (-) | 1:1626201 | 104 | BCAL1468(-) | COG0644: |
| MST2027 (+) | 1:2465614 | 32 | BCAL2229(-) | Hypothetical signal peptide protein (COG3000: Sterol desaturase, lipid metabolism) |
| MST2029 (-) | 1:2554533 | 153 | BCAL2302(-) | COG0556, |
| MST2029 (-) | 1:2554533 | 106 | BCAL2303 (+) | COG1448, |
| MST2034 (+) | 1:2903040 | 55 | BCAL2638 (+) | COG0165, |
| MST2035 (+) MST052 | 1:3009329 | 9 | BCAL2739 (+) | COG0480, |
| MST2038 (+) | 1:3351536 | -15 | BCAL3058 (+) | COG0043, |
|
|
1:3488874 | 117 | BCAL3191(+) | COG1960: |
| MST2043 (+) | 1:3745369 | 60 | BCAL3419 (+) | COG0757: |
| MST2045 (+) | 2:11142 | 137 | BCAM0010(+) | |
|
|
2:84847 | 55 | BCAM0077(-) | COG0654: |
| MST2055 (+) | 2:1564008 | 139 | BCAM1405(-) | |
|
|
2:2088113 | 71 | BCAM1870 (+) | |
| MST2061(+) | 2:2134837 | 112 | BCAM1922(+) | |
| MST2064 (-) | 2:2839793 | 44 | BCAM2502(-) | COG0757: |
| MST2064 (-) | 2:2839793 | 125 | BCAM2503(+) | COG3185: |
| MST2065 (-) | 2:2938113 | 48 | BCAM2588(-) | |
|
|
||||
|
|
||||
|
|
||||
| MST2024 (+) | 1:1735446 | 71 | BCAL1564 (-) | Hypothetical proteins Mup46, Mup47 and Mup48 [phage tail protein] |
| MST2060 (+) | 2:2096677 | 28 | BCAM1879 (+) | Phage antirepressor |
|
|
||||
|
|
||||
|
|
||||
| MST2006 (-) | 1:616909 | 88 | BCAL0562(-) | COG2747, |
|
|
1:778996 | 59 | BCAL0715(-) | COG0583: LysR-type transcriptional regulator |
| MST2013 (+) | 1:1085981 | 40 | BCAL0999 (+) | COG3073: RseA; Negative regulator of sigma E activity (RseB or MucB, negative regulator for alginate biosynthesis) |
| MST2019 (-) | 1:1437591 | 385 | BCAL1318 (+) | COG3707, |
| MST2026 (+) | 1:2016418 | 259 | BCAL1826 (+) | |
| MST2036 (-) | 1:3153030 | 18 | BCAL2871(-) | COG3073, |
|
|
1:3488874 | 102 | BCAL3190(-) | COG1414: Transcriptional regulator, IclR family |
| MST2040 (-) | 1:3502381 | 36 | BCAL3205(-) | COG1396: |
|
|
2:11142 | 22 | BCAM0009(-) | COG1396: |
|
|
2:84847 | 58 | BCAM0076(-) | COG1309: ArcR domain: Bacterial regulatory proteins, tetR family |
| MST2055(+) | 2:1564008 | 64 | BCAM1406(+) | COG: |
| MST2057 (+) | 2:1959876 | 36 | BCAM1750 (+) | COG1846: Transcriptional regulator, MarR family |
| MST2058f (+) | 2:2087487 | 31 | BCAM1868(-) | |
| MST2071 (+) | 3:836110 | 40 | BCAS0752(-) | COG0583: LysR type Transcriptional regulator |
|
|
||||
|
|
||||
|
|
||||
| MST2003 (+) | 1:351306 | 25 | BCAL0321 (+) | COG3671: Predicted membrane protein ( |
|
|
1:366026 | 206 | BCAL0340 (+) | COG0457: TPR repeat, ( |
|
|
3:478440 | 108 | BCAS0409 (+) | |
|
|
||||
| Transport | ||||
|
|
||||
| MST2001 (-) | 1:61816 | 272 | BCAL0051 (+) | COG0834: ABC-type amino acid transport/signal transduction systems |
|
|
2:2974227 | 115 | BCAM2626 (+) | |
| MST2072 (+) | P:55610 | 113 | PBCA053 (-) | COG1638, |
|
|
||||
| Unknown | ||||
|
|
||||
|
|
1:366026 | 181 | BCAL0339(-) | COG3521: Uncharacterized protein conserved in bacteria |
| MST2025 (+) | 1:1979817 | 274 | BCAL1791 (-) | COG2606: Uncharacterized conserved protein |
| MST2047 (-) | 2:169540 | 86 | BCAM0148 (+) | Putative vgr-related protein ( |
| MST2051 (-) | 2:1150388 | -37 | BCAM1044(-) | no homology (COG1536: Flagellar motor switch protein) |
| MST2053 (-) | 2:1467792 | 28 | BCAM1328-329 (+) | Unknown proteins |
| MST2061 (+) | 2:2134837 | 59 | BCAM1921-919 (-) | no homologs |
|
|
3:329197 | 160 | BCAS0293(-) | |
a MSTs were identified by searching the
b The location center of the predicted motif is reported as chromosome:nucleotide. (+) or (-) refers to the DNA strand encoding the motif sequence. The motif names in bold were used to generate the PSSM file.
c Number of base pairs between the centre of the motif and the predicted translational start site.
d Open reading frame number from the unpublished annotation of the
e Gene and domain homologies were obtained using the standard protein-protein BlastP program as described in the methods. Genes in parantheses are downstream of the first orf following the motif and may be in the same operon.
f Confirmed to be CepR regulated by either
Bacterial strains and plasmids used in this study.
| Strain or plasmid | Description and relevant genotype | Source |
|
|
||
| DH5α | φ80d |
Invitrogen |
| SM10 | Mobilizing strain, RP4 |
[50] |
| DH10B | F- |
Invitrogen |
| JM109 F' | Promega | |
|
|
||
| K56-2 | Cystic fibrosis respiratory isolate | [51] |
| K56-R2 | [11] | |
| K56-I2 | [11] | |
| K56-dI2 | [35] | |
| CLW101 | [20] | |
| K56-I2-P1 | BCAM03092:: Tn |
This study |
| K56-I2-P3 | BCAM0957:: Tn |
This study |
| K56-I2-P5 | BCAS0293:: Tn |
This study |
| K56-I2-P9 | BCAM2631:: Tn |
This study |
| K56-I2-P12 | BCAM2630:: Tn |
This study |
| K56-I2-2PB2 | Tn |
This study |
| K56-I2-NB12 | BCAM1187:: Tn |
This study |
| Plasmids | ||
| pCR®2.1 TOPO | PCR cloning vector, pUC ori, P |
Invitrogen |
| pOT182 | pSUP102(GM)::Tn |
[40] |
| pALTER®- |
mutagenesis plasmid, Tcr | Promega |
| pSLS225 | pUCP26 with 1.5 kb |
[11] |
| pCPI101 | pCR®2.1 TOPO with a 266 bp fragment containing the |
This study |
| pCPI201 | pAlter®- |
This study |
| pMS402 | Broad host range vector with promoterless |
[29] |
| pCPI301 | pMS402 with the |
This study |
| pCPI303-313 | pMS402 containing the |
This study |
| pRK2013 | ColE1 Tra (RK2)+, Kmr | [52] |
| pPHU301 | pMS402 containing the |
This study |
| pAYL301 | pMS402 containing the acyltransferase promoter region | This study |
| pSCP301 | pMS402 containing the |
This study |
| pAID301 | pMS402 containing the |
This study |
| pMST005 | pMS402 containing the MST005 promoter region | This study |
| pMST011 | pMS402 containing the MST011 promoter region | This study |
| pMST028 | pMS402 containing the MST028 promoter region | This study |
| pMST052 | pMS402 containing the MST052 promoter region | This study |
| pMST059 | pMS402 containing the MST059 promoter region | This study |
| pMST068 | pMS402 containing the MST068 promoter region | This study |
| pMST112 | pMS402 containing the MST112 promoter region | This study |
Oligonucelotide primers
| Primer | Sequence | Restriction Site or size of product (bp) | |
| PCR Oligonucleotides | |||
|
|
|||
| cepIfor | CAGGCGGCGATAGCTTG | ||
| cepIrev | CACAGATCCGAGGACATCCA | ||
| EXcepR3 | CG |
||
| EXcepR2 | CG |
||
|
|
|||
| oligonucleotides used to clone promoters | position of 5' basea | Size (bp) | |
|
|
|||
|
|
CAGATTCAATGTCGCG | 3:329288 | 272 |
| GCACATCGGTAACGCG | 3:329016 | ||
|
|
CTGCAACGAACGACGCG | 2:1062555 | 294 |
| GACGGAAGGGGAAGGGC | 2:1062261 | ||
|
|
GCCTGCAGGGCACAACGACGCCTATCATGC | 2:2087932 | 267 |
| GAACGAAGGTCTGCATGGATG | 2:2088199 | ||
| PBP | CGTCGGGAACGAGGCCC | 2:2983704 | 313 |
| CGATGGGTTGGCGGTGGG | 2:2983391 | ||
|
|
CGTGTCGATGATCCGCG | 2:2973940 | 404 |
| CACAGGTGGTCTCCC | 2:2974344 | ||
| acyltransferase | CGATACACTGTGAGCCG | 2:446287 | 336 |
| GTCCTTCAGCACGCCG | 2:445951 | ||
|
|
CTCGAGGCTGGCCGGTACTG | 3:478051 | 638 |
| GGATCCAGACTGAAGGCGGACG | 3:478689 | ||
| MST005 | GCACGCCCGCGTCAGGCG | 1:366108 | 325 |
| CGCAAGCCACCACTACCCC | |||
| MST011 | CCTTGCTGAGATTGCCGGC | 1:779005 | 321 |
| GACAGCGCGTTCACGGGCG | |||
| MST028 | CGTGTCGTTGCGGCGCGC | 1:1484174 | 451 |
| GTCTGGCTGTACGCACGCC | |||
| MST052 | CCGTCATTTGTCGTCGGGC | 1:3009328 | 341 |
| CCAGTCCATCGTGGCCGC | |||
| MST059 | CGCCTTCGGCAGCCCCG | 1:3488873 | 315 |
| GCTGGTCGAGCAGCAGCGG | |||
| MST068 | CGTCGAGCGTCAGCTTGCGC | 2:11203 | 325 |
| GGTCGAGCGTCCCGCGC | |||
| MST072 | GCATCCAGCAGGCGCGC | 2:84846 | 398 |
| CCGACGGGACCGCAGCCC | |||
| MST112 | GCAGGTCGCCATGCCGGG | 2:2156170 | 441 |
| ACCACGCGTACGCGGGC | |||
|
|
|||
| Mutagenic Oligonucleotides | |||
|
|
|||
| CepBx103 | GCGTCTTTACGC |
||
| CepBx104 | GTCTTTACGCCGT |
||
| CepBx105 | CGCCGTCACCC |
|
|
| CepBx106 | GCCGTCACCCTG |
||
| CepBx107F | ACGCCGTCACCCTGTA |
||
| CepBx107R | GAGGAGCCTGTAACTGGT |
||
| CepBx108F | CCGTCACCCTGTAAGAG |
||
| CepBx108R | GCACGAGGAGCCTGTAAC |
||
| CepBx109F | CACCCTGTAAGAGTTACC |
||
| CepBx109R | GCGCGGCACGAGGAGCCT |
||
| CepBx110F | CCTGTAAGAG TTACCAGTTA |
||
| CepBx110R | CAGCGCGCGG CACGAGG |
||
| CepBx111F | AGAGTTACCAGTTACAGG |
||
| CepBx111R | CATTACAGCGCGCGGCAC |
||
| CepBx112F | GTTACCAGTTACAGGCTC |
||
| CepBx112R | GTGCATTACAGCGCGCGG |
||
| CepBx113F | CCAGTTACAGGCTCCTC |
||
| CepBx113R | GCGTGCATTACAGCGCG |
||
a Locations reported as chromosome:nucleotide